A Case of Pseudomonas Orbital Cellulitis Following Glaucoma Device Implantation.
Aged, 80 and over
Anti-Bacterial Agents
/ therapeutic use
Device Removal
Eye Infections, Bacterial
/ diagnosis
Female
Glaucoma Drainage Implants
/ adverse effects
Glaucoma, Open-Angle
/ physiopathology
Humans
Intraocular Pressure
/ physiology
Orbital Cellulitis
/ diagnosis
Piperacillin, Tazobactam Drug Combination
/ therapeutic use
Prosthesis Implantation
/ adverse effects
Prosthesis-Related Infections
/ diagnosis
Pseudomonas Infections
/ diagnosis
Pseudomonas aeruginosa
/ isolation & purification
Tomography, X-Ray Computed
Journal
Journal of glaucoma
ISSN: 1536-481X
Titre abrégé: J Glaucoma
Pays: United States
ID NLM: 9300903
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
pubmed:
21
9
2018
medline:
4
1
2020
entrez:
21
9
2018
Statut:
ppublish
Résumé
Orbital cellulitis is a rare complication of aqueous tube shunt surgery. Nine cases have been described in the literature, though the microbiologic etiology is rarely reported. Management with intravenous antibiotics and/or explantation has been described. This is a case report and literature review. A 64-year-old woman developed pain, periorbital swelling, limited extraocular motility, proptosis, and conjunctival injection 3 days following implantation of an Ahmed Glaucoma Valve. Computed tomography of the orbits with contrast showed soft tissue fat stranding consistent with orbital inflammation. Initial medical management with topical and intravenous ceftriaxone and vancomycin was unsuccessful. Surgical removal of the implant was performed and intraoperative cultures demonstrated florid Pseudomonas aeruginosa growth. Antibiotic coverage was changed to Piperacillin-Tazobactam for 3 days, with eventual resolution of her orbital symptoms. We report the first case of orbital cellulitis after implantation of a glaucoma device associated with P. aeruginosa. Failure of intravenous and topical antibiotics led to explantation of the valve and targeted intravenous antibiotic therapy with subsequent clinical improvement.
Identifiants
pubmed: 30234747
doi: 10.1097/IJG.0000000000001095
doi:
Substances chimiques
Anti-Bacterial Agents
0
Piperacillin, Tazobactam Drug Combination
157044-21-8
Types de publication
Case Reports
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM